Cancer is the plague of the modern age. It is very prevalent, to the point where it is estimated that one in two male Americans will develop some kind of cancer during their lifetime. The prognosis is slightly better for women, but it is
MoreNovartis announced the Health Sciences Authority (HSA) has approved* Piqray®, an α-specific class I phosphatidylinositol-3-kinase (PIK3CA) inhibitor, for the treatment of
MoreCancer is the plague of the modern age. It is very prevalent, to the point where it is estimated that
More